Clinical Trials Directory

Trials / Unknown

UnknownNCT04770961

Erector Spinae Plane Block for Minimally Invasive Mitral Valve Surgery

Erector Spinae Plane Block for Minimally Invasive Mitral Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this project is to study whether local anesthetic via the erector spinae plane (ESP) block may be beneficial in minimally invasive mitral valve surgery (MIMVS).

Detailed description

This is a double blinded randomized controlled trial comparing a control group receiving cryoablation and sham block with an intervention group receiving cryoablation and ESP catheter. The primary outcome is total oral morphine equivalent (OME) consumption within the first 48 hours of recovery including intra-operative usage. Secondary outcomes to be evaluated would include pain scores, functional milestones like time to extubation, time to first PO intake, time to ambulation, time to chest tube removal, length of ICU and total hospital stay, complications, and patient satisfaction.

Conditions

Interventions

TypeNameDescription
PROCEDUREErector spinae plane catheter with 0.5% RopivacaineUltrasound guided, right sided, ESP catheter inserted at the level of T5. 20 cc injection of 0.5% Ropivacaine is injected at the time of catheter placement. Postoperatively, a programmed intermittent bolus infusion of 0.2% Ropivacaine will be delivered via the ESP catheter.
PROCEDUREErector spinae plane catheter with salineUltrasound guided, right sided, ESP catheter inserted at the level of T5. 20 cc injection of saline is injected at the time of catheter placement. Postoperatively, a programmed intermittent bolus infusion of saline will be delivered via the ESP catheter.

Timeline

Start date
2021-04-01
Primary completion
2022-06-30
Completion
2022-08-30
First posted
2021-02-25
Last updated
2021-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04770961. Inclusion in this directory is not an endorsement.